glp-1 antagonist mechanism of action Possible mechanisms of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight Mechanisms of GLP-1 Receptor Agonist-Induced
Description
The growing burden of diabetes across Africa provides an opportunity to rethink how intellectual property, public health and industrial policy interact before the continent faces another access crisis
SGLT2 inhibitors are prescription oral medications used to treat type 2 diabetes, which includes empagliflozin (Jardiance)
Wegovy is a weight loss drug with the active ingredient semaglutide
doi: 10.1016/S0140-6736(18)31773-2
